Roy Exum: My Pimples And Andrea Sloan

Monday, September 30, 2013 - by Roy Exum
Roy Exum
Roy Exum

A real long time ago I was having a fit with acne. I was a lovelorn teenager, infatuated with pretty girls in a dizzy game where pimples can really become cumbersome. It seemed like nothing was working and, after I grew a pimple large enough for its own zip code, I finally found a genius doctor who quickly became my lifelong hero when he came up with a marvelous idea.

At the time there was a new “super drug”  that was languishing through years of “clinical trials” in the United States and nobody could get any, despite the fact the revolutionary medicine was already available in Germany. My hero called up a close friend who was a German doctor and – presto! – the first 250 pills came flying across the ocean.

I had to promise that I would not sue anybody if I grew an extra set of ears, developed female breasts, or my eyes turned yellow, but, honestly, I would have dyed my hair green to get the American-made medicine. After I took a course of what was then identified by only a strange laboratory number, my pimples and my acne were gone forever. I had Clark Gable looks and never looked back. That’s a true story (except the Gable part.)

Other fellow Americans had to wait for many months. I don’t believe that's right. Since this occurred in my formative years, I have cursed the federal Food and Drug Administration for much of my adult life because the “clinical trials” process we use is horribly dysfunctional and in critical need of an overhaul.

To illustrate my point, allow me to introduce a beautiful Texas lawyer, Andrea Sloan. Yes, she is quite pretty but “beautiful” because her career has been as the executive director of a Texas advocacy project that provides free legal services to low-income victims of domestic or sexual abuse.

Andrea is a victim herself, not just of stage 3c ovarian cancer but a horribly-tangled FDA system. Her doctors have exhausted every known method to save her life. Six years of surgery, radiation, and chemotherapy haven’t worked. She’s still very much a patient at the world-famous M.D. Anderson Medical Center and her oncologist believes an experimental drug called “BMN 673” might well save Andrea’s life.

M.D. Anderson has a good supply of BMN 673 on hand but with millions of dollars at stake, the manufacturer, BioMarin in California, has said no. “It would be unethical and reckless to provide end-stage refractory ovarian cancer patients outside clinical trial with BMN 673 at this early stage of development,” said spokesperson Debra Charlesworth.

“If we did,” Charlesworth explained to CNN, “we would be exposing the experimental drug to a large group without adequate testing. There have been previous circumstances where early access to large groups has resulted in adverse consequences that were worse than the course of the disease.”

I am certain no scientist can hardly wait for somebody to try to explain to me what “adverse consequences” could possibly be worse than what Andrea Sloan is facing without BMN 673. Andrea is pleading for the drug – let the petals of the flower fall where they may – and probably understands the risks as much as anyone involved. She knows what will happen if she fails to get BMN 673 better than anyone else, too.

Here is what she wrote in a statement to the drug company: “I recognize the importance of weighing the risk and the myriad of considerations they face as a company. However, this is a risk worth taking. I will thank them. My family will thank them. An amazing army of loyal supporters, to whom I owe a debt of gratitude, will thank them. In America we do not leave our wounded warriors on the battleground. BioMarin, please be the Calvary that saves me.”

Her M.D. Anderson doctors believe Andrea is a great candidate. Further, the FDA itself has just announced Ms. Sloan qualifies for a “compassionate care” waiver in the rules but the manufacturer, BioMarin, still says no. The word is BioMarin stands to make about $500 million on the drug and, even though they say they plan to give away 10 percent of the medicine to charity, they refuse to face the ethical dilemma.

As of Sunday afternoon Andrea had almost 170,000 supporters on her Change.org webpage and politician Newt Gingrich, co-host of CNN’s “Crossfire” program, is irate at “a corporation protecting its wallet at the expense on Andrea’s possibly dying. If you want to know why big companies often get bad names, it’s explaining that clerical support to fill out FDA paperwork is too difficult when you can save a life.”

Dr. Charles Levenback, Andrea’s doctor, is disappointed at BioMarin’s stance but, as a man who sees the fight against cancer every day, he told CNN reporters, “My own belief is that the drug companies, the manufacturers, the insurance companies, the providers like my hospital M.D. Anderson, the individual medical professionals, the investigators, the patients -- everybody wants the same things. Safe, effect, novel therapies for as many people as it's appropriate for. Even BioMarin, I believe. I don't think this is like 'Let the masses eat cake.' I think they're on the same mission. But the whole system is giving this dysfunctional result."

On Andrea Sloan’s Facebook page there is a picture that tells of “Three Simple Rules.” The text reads, “If you don’t go after what you want in life, you will never have it. If you don’t ask, the answer will always be No. If you don’t step forward, you’ll always be in the same place.”

Those three rules got rid of my pimples but all we can do is pray for Andrea Sloan. She needs it right now.

royexum@aol.com


Roy Exum: What Voters Think

There are over 9,000 students who attend Quinnipiac University in Hamden, Conn., which – in an effort to be relative -- is just a touch smaller than our UT-Chattanooga. What makes Quinnipiac unique is that it is home of The Quinnipiac University Polling Institute, which produces what’s called the “Q Poll” because hardly anybody knows how to pronounce “Kwin-uh-pe-ack.” The Q ... (click for more)

Not Thrilled With The Parking Rate Increase

Mark your calendars for Sept. 1—the day the Chattanooga Parking Authority has announced it will raise parking rates around the city. In addition to the rate hikes, the Parking Authority will extend enforceable hours from 4:30-6 p.m.  and will include Saturdays as well. The Parking Authority has allowed for a learning curve, however, saying that during the month of September, ... (click for more)

1 Person Killed In Wreck On I-75 SB Involving 2 Tractor-Trailers And 3rd Vehicle; Volkswagen Drive Exit Closed

One person was killed in a wreck on Interstate 75 involving three vehicles early Monday morning. Two of the vehicles were tractor-trailers. The accident happened at approximately 6:28 a.m. at the southbound lanes of 700 I-75. The southbound lanes at the Volkswagen Drive exit were closed. TDIT said the wreck was near the Bonny Oaks Drive/Collegedale exit. ... (click for more)

Woman Seriously Injured After Plowing Into Rossville Boulevard Car Dealership Saturday Evening

A woman was seriously injured after plowing her vehicle into a car dealership on Rossville Boulevard on Saturday evening.   At approximately  6:49 p.m., the Chattanooga Police Department responded to 2818 Rossville Blvd. on an accident with injuries.   A blue vehicle traveling at a high rate of speed lost control.  The vehicle crashed ... (click for more)

UTC, Jacksonville State Tickets In '30 Minutes or Less' On Monday

Don't have your tickets to the Jacksonville State game yet?  If you work or live within five miles of campus, Monday will be one last chance to get them delivered in '30 Minutes or Less' or they are FREE.  This is for tickets to Saturday's season opener, or a full order of season tickets.  Only ticket orders made over the phone are eligible for this promotion. ... (click for more)

Baylor Sweeps Two Nashville Teams In Volleyball Saturday

Volleyball teams from Brentwood Academy and Pope John Paul II have at least one thing in common on Saturday following matches with Baylor and GPS.  They both headed back to Nashville with a win and a loss as both beat GPS and both lost to Baylor. Baylor improved to 13-1 overall and 3-0 in region play with Saturday's two wins, including a 3-1 verdict over Brentwood ... (click for more)